No definition available.
Chondrosarcoma, excluding all cancers (controls excluding all cancers)
C3_CHONDROSARCOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
163 |
4. Check minimum number of eventsNone |
163 |
5. Include endpointsNone |
163 |
6. Filter based on genotype QC (FinnGen only) |
163 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Chondrosarcoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 163 | 78 | 85 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 56.95 | 56.81 | 57.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 94
- Matched controls
- 938
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
206.5
29.5
29
*
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
25.1
23
*
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
24.0
22
*
130
Kela drug reimbursment
Malignant tumour
+∞
16.1
15
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
16.1
15
*
C41.32
ICD-10 Finland
Chondrosarcoma of the ribs, sternum and clavicle
+∞
15.0
14
*
9220/3-C41.3
ICD-O-3
Chondrosarcoma, NOS, of rib, sternum, clavicle and associated joints
+∞
15.0
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
6.4
14.5
47
127
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
13.9
13
*
C41.82
ICD-10 Finland
Overall chondrosarcoma in bone and articular cartilage
+∞
11.7
11
*
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
123.2
10.7
11
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
10.6
61
278
9220/3-C40.0
ICD-O-3
Chondrosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.6
10
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
61.6
9.9
11
*
XX3DW
NOMESCO Finland
Time consuming IT work
10.8
9.6
18
20
9220/3-C41.4
ICD-O-3
Chondrosarcoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
9.5
9
*
JN4BD
NOMESCO Finland
Extensive body CT
10.3
9.3
18
21
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
11.3
9.2
17
18
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.8
9.1
18
22
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
8.5
8
*
WZC30
NOMESCO Finland
Teaching
6.6
8.2
21
39
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
49.2
7.9
9
*
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
49.2
7.9
9
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
10.7
7.6
14
15
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
+∞
7.4
7
*
C32.3
ICD-10 Finland
Malignant neoplasm: Laryngeal cartilage
+∞
7.4
7
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
7.4
7
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
+∞
7.4
7
*
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
7.4
7
*
NF3AA
NOMESCO Finland
Femur X-ray examination
22.1
7.3
10
5
B01AB05
ATC
enoxaparin; parenteral
3.5
7.3
43
182
H02AB02
ATC
dexamethasone; systemic
43.3
6.9
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.7
6.7
19
40
A03FA01
ATC
metoclopramide; systemic, rectal
5.4
6.7
20
45
R4110
NOMESCO Finland
Physiotherapy
3.5
6.6
37
148
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
74.7
6.5
7
*
WX402
NOMESCO Finland
General anaesthesia
4.5
6.4
23
63
A04AA02
ATC
granisetron; systemic, transdermal
+∞
6.3
6
*
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
6.3
6
*
9220/3-C41.0
ICD-O-3
Chondrosarcoma, NOS, of bones of skull and face and associated joints
+∞
6.3
6
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
6.3
6
*
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
6.3
6
*
C41.22
ICD-10 Finland
Chondrosarcoma of the spine
+∞
6.3
6
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
GD1AD
NOMESCO Finland
Thorax CT examination
11.1
6.2
11
11
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.1
6.2
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
31
36
10.40
25.40
1.2
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
83
354
3.74
15.56
3.0
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
88
398
3.63
14.93
2.6
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
63
263
3.27
11.59
3.0
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
98
530
3.13
11.46
4.5
3.8
—
—
—
0
0
(3002256) Pathology report gross observation
32
94
3.99
9.93
1.3
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
40
141
3.43
9.48
8.2
11.7
mmol/l
0.8
1.5
0.77
32
112
(3032080) INR in Blood by Coagulation assay
89
502
2.70
8.91
6.0
8.9
inr
1.1
1.3
1.79
22
127
(3021788) Differential panel - Synovial fluid
13
21
6.64
7.84
1.5
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
60
294
2.65
7.76
4.4
3.2
%
85.4
90.0
0.85
60
287
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
23
65
3.96
7.45
2.5
1.8
ug/l
1.9
3.0
1.99
16
48
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
95
597
2.42
7.01
8.2
7.0
mmol/l
1.2
1.2
1.08
82
524
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
89
544
2.40
6.99
7.0
6.6
mmol/l
1.2
1.2
1.11
79
482
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
21
6.09
6.69
1.6
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
33
4.90
6.60
2.4
2.4
u/ml
0.3
0.4
—
8
15
(3013650) Neutrophils [#/volume] in Blood by Automated count
104
707
2.30
6.05
10.6
6.2
e9/l
4.5
4.3
0.09
95
613
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
129
968
2.59
5.91
9.8
5.2
u/l
77.9
74.2
0.71
124
888
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
22
73
3.33
5.62
11.7
11.3
%
1.3
1.6
0.96
22
73
(3013826) Glucose [Moles/volume] in Serum or Plasma
108
761
2.24
5.55
6.0
5.1
mmol/l
6.7
6.8
0.25
101
701
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
63
3.48
5.53
4.3
18.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
22
74
3.28
5.50
11.9
11.2
%
0.9
0.7
0.81
22
74
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
19
59
3.51
5.36
12.1
10.5
mmol/l
24.2
24.9
0.61
19
54
(3007853) Bacteria identified in Skin by Aerobe culture
34
154
2.53
4.97
1.9
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
107
2.70
4.58
2.4
3.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
56
325
2.10
4.55
5.0
4.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
50
282
2.12
4.36
7.3
4.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
85
582
1.96
4.30
6.3
5.5
%
8.4
8.5
0.01
79
542
(42870588) Differential panel, method unspecified - Blood
64
399
1.99
4.23
5.3
5.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
86
594
1.95
4.22
6.2
5.3
%
25.4
28.2
1.27
78
551
(3006504) Eosinophils/100 leukocytes in Blood
84
578
1.94
4.14
5.9
5.2
%
3.0
3.1
0.09
78
534
(3015377) Calcium [Moles/volume] in Serum or Plasma
62
385
1.99
4.13
4.9
2.0
mmol/l
2.4
2.3
0.24
57
311
(3019198) Lymphocytes [#/volume] in Blood
90
643
1.89
3.88
5.4
5.2
e9/l
1.7
1.9
0.78
76
569
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
29
4.00
3.87
1.8
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
76
515
1.89
3.85
4.5
3.8
g/l
34.7
36.0
1.08
69
477
(3022096) Basophils/100 leukocytes in Blood
81
561
1.88
3.83
6.1
5.2
%
0.7
0.7
0.26
75
518
(3013115) Eosinophils [#/volume] in Blood
91
655
1.88
3.80
5.4
5.4
e9/l
0.2
0.2
0.48
77
574
(3001604) Monocytes [#/volume] in Blood
88
628
1.87
3.77
5.2
5.2
e9/l
0.6
0.6
0.16
76
545
(3018010) Neutrophils/100 leukocytes in Blood
84
592
1.86
3.73
5.9
5.1
%
58.8
57.3
0.48
77
551
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
17
62
2.94
3.72
12.7
7.4
mmol/l
24.4
24.8
0.30
17
62
(3006315) Basophils [#/volume] in Blood
88
632
1.85
3.66
5.3
5.2
e9/l
0.0
0.0
0.14
76
546
(3014111) Lactate [Moles/volume] in Serum or Plasma
23
103
2.44
3.41
11.4
7.2
mmol/l
0.9
1.4
2.85
23
96
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
7
8.84
3.29
1.7
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
20
87
2.48
3.15
3.4
11.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
18
77
2.50
2.94
5.1
4.8
%
0.8
0.3
—
10
12
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
7
13
5.57
2.90
3.4
7.2
mg/l
10.8
12.8
—
7
13
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
23
111
2.25
2.90
4.8
3.2
u/l
241.1
240.6
0.01
23
103
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
23
4.08
2.82
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
23
4.08
2.82
1.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
47
301
1.79
2.69
1.4
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
19
88
2.31
2.63
1.6
2.2
g/l
0.2
0.2
0.92
19
77
(3000991) Gas panel - Venous blood
20
95
2.26
2.62
13.3
9.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
72
525
1.67
2.57
11.1
7.8
e9/l
0.0
0.0
0.39
56
413
(3031040) Bacteria [#/volume] in Urine by Automated count
103
830
1.65
2.44
4.5
4.2
—
243.1
—
0
15
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
8
6.40
2.39
3.4
1.4
pg
31.4
32.8
—
5
8
(3021440) Promyelocytes/100 leukocytes in Blood
17
79
2.29
2.34
5.3
4.7
%
0.2
0.0
—
10
14
(3042936) Bacteria identified in Isolate by Culture
32
191
1.84
2.28
2.5
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
18
87
2.20
2.27
5.2
4.4
%
1.8
0.7
—
10
19
(3025159) Blasts/100 leukocytes in Blood
16
76
2.23
2.10
5.6
4.7
%
0.0
6.7
—
9
13
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
10
5.12
2.08
1.4
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
15
4.11
2.06
4.0
5.1
%
66.8
56.6
—
6
15
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
31
195
1.73
1.86
1.8
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
112
958
1.54
1.76
4.4
4.0
mm/h
14.7
11.5
1.06
106
875
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
143
1299
1.82
1.74
20.7
12.6
mg/l
26.2
23.9
0.39
126
972
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
13
3.93
1.73
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
108
919
1.52
1.72
3.5
3.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
137
1.79
1.66
1.7
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
50
368
1.52
1.59
3.5
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
64
2.12
1.59
2.2
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
15
3.40
1.53
4.0
4.1
e9/l
5.6
3.9
—
5
15
(3044941) Cell count panel - Synovial fluid
5
15
3.40
1.53
2.0
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
110
1231
0.67
1.51
6.3
6.2
mmol/mol
40.1
40.6
0.16
98
1148
(3022145) Colonoscopy Study observation
20
118
1.79
1.49
1.4
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
147
1361
1.82
1.46
24.7
15.5
mmol/l
139.3
139.7
0.96
142
1317
(3023103) Potassium [Moles/volume] in Serum or Plasma
147
1362
1.81
1.44
24.6
15.5
mmol/l
3.9
4.0
1.67
141
1318
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
7
29
2.48
1.41
1.3
3.0
g/l
4.3
4.2
—
7
29
(3019225) pH of Specimen
21
129
1.72
1.38
3.3
3.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
138
1.69
1.35
1.7
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
119
0.40
1.30
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
18
2.83
1.29
1.4
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
35
2.35
1.29
1.9
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
49
2.11
1.25
1.7
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
86
1.82
1.24
6.2
3.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
46
351
1.43
1.20
2.6
3.3
ph
7.4
7.4
0.03
12
45
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
124
1341
0.69
1.19
4.3
5.2
mmol/l
2.6
2.7
0.54
106
1244
(3017732) Neutrophils [#/volume] in Blood
16
95
1.76
1.19
5.3
2.1
e9/l
3.3
3.9
0.54
11
76
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
34
0.00
1.17
0.0
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
121
1313
0.70
1.16
4.1
4.7
mmol/l
4.5
4.6
0.52
105
1224
(3044290) Cell count panel - Cerebral spinal fluid
5
20
2.55
1.16
1.8
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
20
2.55
1.16
2.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.55
1.16
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
36
0.00
1.15
0.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
58
1.96
1.15
2.4
4.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
30
2.39
1.14
1.0
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
19
121
1.65
1.11
1.8
1.9
u/l
32.4
31.5
0.06
14
94
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
82
1.77
1.09
2.0
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
45
2.06
1.07
1.8
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
13
75
1.80
1.06
2.6
3.6
mmol/l
1.9
1.8
0.03
13
50
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
121
1306
0.71
1.03
4.1
4.6
mmol/l
1.5
1.5
0.02
104
1211
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
30
0.00
0.98
0.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
85
1.71
0.98
1.9
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
86
1.69
0.94
2.7
1.8
ml/min/173m2
65.7
63.3
—
6
29
(3029937) Albumin [Presence] in Urine by Test strip
42
329
1.37
0.94
5.4
3.7
estimate
0.0
0.0
0.00
20
91
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
179
1.47
0.91
5.8
6.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
114
0.51
0.86
1.5
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
174
1.44
0.83
3.8
4.6
%
32.8
32.6
0.04
15
112
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
132
1234
1.37
0.80
20.0
11.2
ml/min/173m2
86.8
80.0
2.54
112
969
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
6
33
1.85
0.80
1.7
1.4
e6/l
293.2
328.5
—
6
26
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
6
33
1.85
0.80
1.7
1.2
e6/l
294.8
3.4
—
6
26
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
0
27
0.00
0.78
0.0
2.0
—
30.2
—
0
22
(3021447) Carbon dioxide [Partial pressure] in Venous blood
8
132
0.59
0.77
3.4
3.5
kpa
6.3
5.7
—
8
126
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
134
0.58
0.77
1.4
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
144
1369
1.44
0.75
21.3
11.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
56
1.64
0.74
2.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
38
463
0.77
0.71
2.9
3.1
mmol/l
6.9
7.7
0.58
29
386
(3012516) Albumin [Mass/volume] in Urine
35
431
0.76
0.70
3.1
3.3
mg/l
2175.7
61.0
0.47
22
282
(3000494) Fungus identified in Specimen by Culture
22
163
1.40
0.69
1.6
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
177
0.65
0.68
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
119
1265
0.78
0.67
3.7
4.2
mmol/l
1.2
1.3
2.28
104
1169
(3019832) Treponema pallidum Ab [Presence] in Serum
6
102
0.57
0.64
2.3
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
137
0.64
0.64
1.4
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
38
457
0.78
0.63
3.8
4.0
mg/mmol
2.7
8.6
2.60
22
294
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
57
493
1.24
0.61
4.8
3.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
151
1458
1.48
0.60
30.6
18.3
e9/l
250.8
245.3
0.49
145
1418
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3020891) Body temperature
8
53
1.54
0.59
3.5
6.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
23
0.00
0.59
0.0
2.0
—
4.1
—
0
23
(3035285) Chloride [Moles/volume] in Venous blood
0
23
0.00
0.59
0.0
2.0
—
105.5
—
0
23
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
23
0.00
0.59
0.0
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
50
428
1.24
0.58
3.5
3.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
151
1459
1.47
0.58
30.6
18.3
e12/l
4.4
4.5
2.86
144
1416
(3010813) Leukocytes [#/volume] in Blood
151
1459
1.47
0.58
30.6
18.3
e9/l
7.1
6.7
0.33
144
1416
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
35
1.74
0.58
2.2
3.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
96
880
1.22
0.58
4.4
4.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
123
0.63
0.57
1.5
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
62
546
1.22
0.55
2.1
2.3
nmol/l
79.7
75.1
0.63
57
481
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
169
0.69
0.55
1.4
1.5
—
—
—
0
0
(4094501)
6
38
1.60
0.55
1.5
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
20
255
0.75
0.52
1.3
1.3
g/l
1.9
2.5
1.74
14
143
(40761535) Cells panel - Urine sediment
15
110
1.40
0.51
3.7
3.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
7
109
0.63
0.50
3.7
2.6
kpa
4.0
4.6
—
7
103
(3036481) Cortisol [Moles/volume] in Serum or Plasma
16
119
1.38
0.50
2.5
1.7
nmol/l
300.3
381.1
1.30
16
107
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
7
50
1.42
0.45
2.3
1.1
g/l
0.8
0.5
—
7
44
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
126
1200
1.22
0.45
4.8
4.5
mu/l
1.9
1.9
0.01
111
1090
(1761868) Lipid panel - Serum or Plasma
40
461
0.82
0.45
2.8
3.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
145
1403
1.30
0.44
13.7
8.7
u/l
24.9
25.3
0.11
136
1343
(3000570) Elastase.pancreatic [Mass/mass] in Stool
5
31
1.63
0.43
1.4
1.4
ug/g
—
285.5
—
0
15
(3012544) pH of Venous blood
10
138
0.71
0.42
3.3
3.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
33
1.53
0.41
1.2
2.5
%
91.4
94.9
—
5
33
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
35
1.44
0.39
1.0
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
59
532
1.17
0.39
4.1
3.7
ng/l
21.3
41.5
1.69
49
372
(3050129) First trimester maternal screen panel - Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
201
0.77
0.38
1.3
1.3
u/ml
2.9
10.5
—
6
76
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
14
108
1.32
0.36
1.9
4.5
ng/l
266.2
209.9
0.13
14
98
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
6
41
1.48
0.36
2.5
1.1
g/l
0.0
0.0
—
6
36
(3045414) Leukocytes [Presence] in Urine
6
42
1.44
0.36
1.5
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
44
1.38
0.35
3.0
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
6
45
1.35
0.34
2.5
1.1
g/l
0.0
0.0
—
6
40
(3013512) EKG study
44
392
1.17
0.34
4.4
3.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
86
0.69
0.34
1.3
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
124
1285
0.85
0.33
4.3
4.6
mmol/l
6.0
6.0
0.10
105
1170
(3037522) Nuclear Ab [Titer] in Serum
13
163
0.78
0.31
1.2
1.4
—
384.0
—
0
45
(3021601) Nitrite [Presence] in Urine by Test strip
67
621
1.13
0.30
5.4
5.0
estimate
0.0
0.0
0.00
19
90
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
85
1.32
0.29
1.2
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
35
311
1.16
0.28
1.9
2.0
mg/l
3.1
3.1
0.01
30
258
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
33
292
1.16
0.28
2.8
3.9
ng/l
41.4
205.6
1.44
28
231
(3000492) Spirometry study
14
113
1.26
0.27
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
224
0.83
0.27
1.1
1.3
iu/ml
20.1
32.9
—
8
66
(3009542) Hematocrit [Volume Fraction] of Blood
121
1168
1.14
0.26
20.4
13.5
%
37.8
40.5
3.26
82
837
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
35
390
0.87
0.26
4.3
3.6
%
20.2
24.4
0.89
15
179
(3022621) pH of Urine by Test strip
6
84
0.70
0.24
2.8
2.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
38
1.33
0.23
1.8
2.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
102
0.77
0.22
1.3
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
102
981
1.11
0.22
4.5
3.7
pmol/l
14.4
14.8
0.96
91
887
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
2.6
—
0
5
(3035320) C reactive protein [Mass/volume] in Body fluid
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
9.4
—
750.0
—
0
10
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.4
—
1248.7
—
0
10
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
25
278
0.88
0.18
2.2
1.7
pmol/l
380.3
438.7
0.75
17
232
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
65
0.76
0.17
1.0
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
34
314
1.10
0.16
2.9
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
31
285
1.11
0.15
4.0
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
65
620
1.08
0.15
4.7
3.6
estimate
0.0
0.0
0.00
19
92
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
51
483
1.08
0.14
4.0
3.7
ug/l
3.2
2.0
0.97
45
432
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
19
211
0.89
0.14
2.5
2.5
e6/l
1.1
1.1
—
10
113
(3009261) Glucose [Presence] in Urine by Test strip
66
633
1.07
0.13
4.5
3.6
estimate
0.0
0.0
0.00
18
87
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
133
1.14
0.12
1.5
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
89
864
1.07
0.12
2.9
2.9
u/l
41.4
45.3
0.40
82
801
(3030467) Casts [#/volume] in Urine by Automated count
35
328
1.09
0.12
3.2
2.8
e6/l
0.3
0.4
0.11
27
234
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
115
0.86
0.11
1.4
1.8
—
—
—
0
0
(3015736) pH of Urine
48
502
0.94
0.10
4.1
3.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
5
48
1.04
0.09
1.6
2.2
ug/l
88.6
368.7
—
5
43
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
267
0.92
0.09
2.4
2.4
ug/l
1.0
0.8
0.64
19
167
(3041096) Erythrocytes [Presence] in Urine by Automated
37
352
1.07
0.09
4.5
3.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
61
0.81
0.08
2.8
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
19
205
0.92
0.08
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
20
215
0.92
0.08
1.6
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
66
1.06
0.08
2.7
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
81
791
1.05
0.08
3.3
2.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
8
78
1.03
0.07
1.6
1.8
g/l
10.0
10.8
—
8
71
(3019150) Specific gravity of Urine by Refractometry
32
307
1.05
0.05
4.1
3.9
kg/l
1.0
1.0
—
6
41
(3002582) Erythrocytes [#/volume] in Urine
38
367
1.05
0.05
3.3
2.9
e6/l
44.6
216.8
0.48
29
281
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
42
410
1.03
0.03
3.0
3.1
ng/l
1427.5
1351.4
0.03
35
349
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
57
561
1.02
0.02
1.8
2.0
pmol/l
97.6
93.3
0.21
33
274
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
27
278
0.97
0.02
1.1
1.3
u/ml
1.3
1.3
0.01
12
70
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
15
157
0.95
0.01
1.3
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
44
433
1.02
0.01
3.8
3.5
e6/l
210.1
86.1
0.30
31
302
(3019309) Folate [Moles/volume] in Red Blood Cells
27
264
1.03
0.00
1.6
1.7
nmol/l
1364.8
1168.8
0.43
19
192
(4010399)
10
96
1.04
0.00
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
26
264
0.98
0.00
5.5
4.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
20
199
1.01
0.00
2.7
2.7
e6/l
3.5
2.5
0.27
11
103
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
1.0
—
0
8
(3028026) IgM [Mass/volume] in Serum or Plasma
6
65
0.92
0.00
1.7
1.4
g/l
1.2
1.2
—
6
60
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44813793)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
25.1
—
0
7
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
1.3
—
0
5
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
17.9
—
0
5
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
5
54
0.92
0.00
1.4
2.6
u/l
40.0
47.4
—
5
47
(4015189)
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
144.2
—
0
6
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
74
0.94
0.00
2.0
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
218.5
—
0
6
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
733.4
—
0
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
9
0.00
0.00
0.0
1.9
—
13.0
—
0
9
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_CHONDROSARCOMA_EXALLC – Chondrosarcoma, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).